Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0298353 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Shuwen Duan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China. Hauptthemen laut MEDLINE: Flavonoids, Epithelial-Mesenchymal Transition, Pyroptosis, Rats, Sprague-Dawley. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Star of Innovation of Excellent Postgraduates in Gansu Province.
Abstract (Originalsprache)
Context
Nephrotic syndrome(NS) has emerged as a worldwide public health problem. Renal fibrosis is the most common pathological change from NS to end-stage renal failure, seriously affecting the prognosis of renal disease. Although tremendous efforts have been made to treat NS, specific drug therapies to delay the progression of NS toward end-stage renal failure are limited. Epimedium is generally used to treat kidney disease in traditional Chinese medicine. Icariin is a principal active component of Epimedium.
Methods
We used Sprague Dawley rats to establish NS models by injecting doxorubicin through the tail vein. Then icariin and prednisone were intragastric administration. Renal function was examined by an automatic biochemical analyzer. Pathology of the kidney was detected by Hematoxylin-Eosin and Masson staining respectively. Furthermore, RT-PCR, Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Western Blot and Terminal-deoxynucleotidyl Transferase Mediated Nick End Labeling staining were employed to detect the proteins related to pyroptosis and EMT. HK-2 cells exposed to doxorubicin were treated with icariin, and cell viability was assessed using the MTT. EMT was assessed using Enzyme-Linked Immunosorbent Assay and Western Blot.
Results
The study showed that icariin significantly improved renal function and renal fibrosis in rats. In addition, icariin effectively decreased NOD-like receptor thermal protein domain associated protein 3,Caspase-1, Gasdermin D, Ly6C, and interleukin (IL)-1β. Notably, treatment with icariin also inhibited the levels of TGF-β, α-SMA and E-cadherin. Discussion and conclusions It is confirmed that icariin can improve renal function and alleviate renal fibrosis by inhibiting pyroptosis and the mechanism may be related to epithelial-to-mesenchymal transition. Icariin treatment might be recommended as a new approach for NS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China.
ORCID-Profile: Shuwen Duan, Enlai Dai
Förderung
- National Natural Science Foundation of China
- Star of Innovation of Excellent Postgraduates in Gansu Province
Zitieren
APA
Duan, S., Ding, Z., Liu, C., Wang, X., & Dai, E. (2024). Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition. PLOS ONE. https://doi.org/10.1371/journal.pone.0298353
Vancouver
Duan S, Ding Z, Liu C, Wang X, Dai E. Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition. PLOS ONE. 2024. doi:10.1371/journal.pone.0298353
BibTeX
@article{Duan2024,
author = {Duan, Shuwen and Ding, Zhaoran and Liu, Can and Wang, Xiaohui and Dai, Enlai},
title = {Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0298353}
}
EUVIMED